Tag: endocrine system

Pay Attention for Signs of Atypical Diabetes

It’s important to be alert for signs that a person with diabetes might be among the minority, of around 5%, who have an atypical type,...

Artificial Pancreas Tried in Type 2 Diabetes Patients on Dialysis

A fully closed-loop artificial pancreas system improved glucose control and reduced hypoglycemia compared with standard insulin therapy in adult outpatients with type 2 diabetes requiring...

Metabolic Surgery Improves Diabetes-Related Quality of Life

Patients with type 2 diabetes who underwent metabolic surgery reported improved general health, mobility, and energy, along with less pain and diabetes-related concerns compared with...

FDA Rejects Teplizumab for Type 1 Diabetes Delay

The US Food and Drug Administration (FDA) has declined to approve the anti-CD3 monoclonal antibody teplizumab (Tzield, Provention Bio) for the delay of type 1...

Insulin-Pramlintide Combo Improves Type 1 Diabetes Control

A novel investigational coformulation of prandial insulin and pramlintide improves blood glucose control and reduces body weight in people with type 1 diabetes, early research...

Digital Diabetes Coaching Systems: Too Expensive or Worthwhile?

Dr Anne L. Peters Digital coaching systems for type 2 diabetes “reduce the need for more expensive, in-person visits,” said Anne L. Peters, MD, arguing...

Heartburn Drugs Improve Blood Sugar Control in Diabetes

WASHINGTON—Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to...

Bring Type 1 Diabetes in Adults Out of the Shadows

A new draft consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) addresses diagnosis and management...

‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes

Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2...

‘Staggering’ Doubling of Type 2 Diabetes in Kids During Pandemic

The incidence of type 2 diabetes in children appears to have doubled during the COVID-19 pandemic, data from two new US studies suggest, with the...

Time-Restricted Eating Is ‘Promising, But More Data Are Needed’

Time-restricted eating — that is, reducing the number of hours a person is allowed to eat during the day — may produce a modest 1%...

Obesity Amplifies Harmful Effects of Alcohol on the Liver

Being overweight or having obesity significantly increases the risk for liver disease and the likelihood of dying from it compared with being of normal weight, regardless...

FDA Approves ‘Gamechanger’ Semaglutide for Weight Loss

The US Food and Drug Administration (FDA) has approved a 2.4 mg/week subcutaneous dose of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy, Novo Nordisk)...

First AACE Guidelines on Diabetes Technology

The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with...

Any Bone Break Increases Risk for Subsequent Fracture in Older Women

No matter where an initial fracture occurs in a postmenopausal woman, there is a subsequent increased risk of another fracture, with the risk surprisingly highest...

FDA Blazes Path for ‘Real-World’ Evidence as Proof of Efficacy

In 2016, results from the LEADER trial of liraglutide in patients with type 2 diabetes helped jumpstart awareness of the potential role of this new...

Most Kids With Type 1 Diabetes and COVID-19 in US Fared Well

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The majority of children with type 1 diabetes who tested positive...

Promising Data on Once-Weekly Insulin, Phase 3 Study Ongoing

Two new phase 2 studies show encouraging findings with the investigational once-weekly basal insulin analogue icodec (Novo Nordisk) for people with type 2 diabetes who...

Wearable Continuous Ketone Monitoring Appears Feasible

Continuous measurement of ketone levels with a wearable device is feasible, new research suggests. A small sensing device worn on the upper arm, similar to...

Eating More Fat May Boost Borderline Low Testosterone

“Low-fat diets appear to decrease testosterone levels in men, but further randomized controlled trials are needed to confirm this effect,” the authors of a meta-analysis...

Type 1 Diabetes and Transgender Identity: Is There a Link?

The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general population, research suggests. This has been reported...

Endocrinologist Charged After Bomb-Making Supplies Found

An endocrinologist in Naples, Florida, faces multiple federal charges after police found homemade explosives and bomb-making supplies, as well as numerous illegal drugs, in his...

Increase in Thyroid Cancer Rates Points to Overscreening

The incidence of thyroid cancer cases has increased markedly since the late 1990s, although rates vary widely between countries, and the increases have been largely...

Eating Fish Links With Fewer CVD Events in High-Risk People

People with cardiovascular disease (CVD) who regularly ate fish had significantly fewer major CVD events and there were fewer total deaths compared with similar individuals...

2021 NRMP Specialty Match Sees Record Numbers

The number of applicants to the Specialties Matching Service (SMS) of the National Resident Matching Program (NRMP) continued to grow this year, as did the...